Singapore Diagnostics

From its establishment in late 2013, Singapore Diagnostics (SGD) has grown to be among the largest laboratories in the Philippines. Processing laboratory tests for over 300 hospitals, clinic labs and healthcare institutions in the Philippines, SGD serves up to 50,000 patients every month. The company is a subsidiary of Pathology Asia (PAH), among Southeast Asia’s large medical diagnostic groups with laboratory, genomic and digital health operations in Singapore, Malaysia, Indonesia, Vietnam and Australia.

See below for the Latest Singapore Diagnostics News, Analysis, Profit Results, Share Price Information, and Commentary.